儿童1型糖尿病管理方面的进展
Mridu Bahal1, Vineeta Pande1, Jasleen Dua1
1Pediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Center, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND.
Cureus
|September 23, 2024
概括
最近1型糖尿病 (T1DM) 管理方面的进展,包括技术和新疗法,正在改善患者的治疗结果. 这些创新提供了更好的血糖控制,并为个性化,潜在的治愈治疗铺平了道路.
科学领域:
- 内分泌学和新陈代谢学
- 儿科内分泌学 儿科内分泌学
- 生物医学工程 生物医学工程
背景情况:
- 1型糖尿病 (T1DM) 管理历来在实现最佳血糖控制和改善生活质量方面面临着挑战.
- 技术和治疗方面的进步对于解决T1DM患者,特别是儿童的复杂需求至关重要.
研究的目的:
- 审查T1DM管理的最新进展.
- 突出影响血糖控制,胰岛素输送和长期治疗策略的创新.
- 探索T1DM研究和个性化医学的未来方向.
主要方法:
- 审查糖尿病管理的最新技术创新,包括持续血糖监测 (CGM) 和胰岛素治疗 (例如混合闭环系统).
- 对新型药物疗法的分析,如超快速起作用的胰岛素,SGLT2抑制剂和GLP-1受体激动剂.
- 检查新兴免疫疗法,β细胞替代策略 (干细胞,封装) 和数字健康平台.
主要成果:
- 像CGM和胰岛素这样的技术创新显著提高了血糖控制,并自动化了胰岛素的输送.
- 新的药物疗法改善了食后葡萄糖管理,减少了胰岛素需求.
- 免疫疗法和细胞替代疗法显示出恢复胰岛素生产的希望.
- 数字健康和远程医疗扩大了患者获得教育和支持的机会.
结论:
- 最近的进展正在改变T1DM管理,导致改善结果和生活质量,特别是儿童.
- 准确医学,人工智能和微生物组的未来研究有可能为个性化和治愈性T1DM治疗提供潜力.
- 这些集体进展减少了疾病负担,并提高了T1DM患者的长期前景.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Management and Pharmacotherapy
244
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
244
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Insulin: Dosing Regimen and Adverse Effects
156
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
156
Diabetes: Symptoms, Diagnosis, and Complications
516
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
516
Pathophysiology of Diabetes
900
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
900


